Atlas Trials

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

Clinical trial NCT07317063 · COMPLETED

Trial details

NCT number
NCT07317063
Sponsor
Grünenthal GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy (DMD)
Start date
2025-11-21
Primary completion
2026-01-06
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.